A complete application in a minute — tailored resume and cover letter, ready to send.
Regeneron Pharmaceuticals, Inc. in Tarrytown, NY is seeking an Associate Scientist to join our Ophthalmology group, supporting ocular immune and inflammatory disease therapies.
This hands-on role involves cell biology, immune assays, and disease-relevant models, collaborating across preclinical programs to advance science and patient impact. The position emphasizes a BS degree with 0–2 years lab experience, strong organization, and a proactive attitude.
Build our future together At Regeneron, we use science and innovation to develop life‑changing medicines for people with serious diseases. We are seeking an Associate Scientist to join our Ophthalmology group, supporting the development of therapies for ocular immune and inflammatory diseases. In this role, you will engage in hands‑on research across cell biology, immune‑focused assays, and disease‑relevant experimental models while collaborating with a team working across multiple preclinical programs. This position offers the opportunity to contribute to a fast‑growing, science‑driven organization making a meaningful difference to patients worldwide.
Location: Tarrytown, NY. Work model/flexibility: Onsite.
This role requires B.S. degree in a relevant field with 0–2 years of experience in a life‑sciences discipline; practical, hands‑on laboratory experience is valued over an advanced degree. Strong organizational skills, attention to detail, and a creative approach to problem‑solving. Open and frequent communication with manager and team members. A positive, proactive attitude and a track record of reliable, broad execution across multiple techniques rather than deep specialization in a single area.
For jobs in Canada: this posting is for an existing position.
Salary Range (annually) $70,300.00 - $110,100.00
Regeneron is an equal opportunity employer and all qualified applicants will receive consideration for employment without regard to race, color, religion or belief (or lack thereof), sex, sexual orientation, gender identity or expression, gender reassignment, marital or civil partnership status, civil status, pregnancy or parental status, age, disability, nationality, citizenship status, ethnic or national origin, membership of the Traveler community, familial status, genetic information, military or veteran status, or any other characteristic protected under applicable law. Where required, we will provide reasonable accommodation to applicants with known disabilities or chronic illnesses during the recruitment process, unless such accommodation would impose undue hardship.
Regeneron offers a competitive and comprehensive total rewards package which may include, depending on country and role: annual bonuses or other incentive plans, equity awards, pension or retirement benefits, 401(k) company match, health and wellness programs, fitness centers, insurance benefits (e.g. medical, dental, vision, life and disability), paid time off, and family support benefits.
For additional information about Regeneron benefits in the U.S., please visit https://careers.regeneron.com/en/working-at-regeneron/total-rewards/. For other locations, additional information will be provided during the recruitment process.
Regeneron is a leading biotechnology company that invents life‑transforming medicines for people with serious diseases. Founded and led for over 30 years by physician‑scientists, our unique ability to repeatedly and consistently translate science into medicine has led to nine FDA‑approved treatments and numerous product candidates in development, almost all of which were home‑grown in our laboratories. Our medicines and pipeline are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, neurology, infectious diseases and rare diseases. Regeneron is also proud of award‑winning culture of innovation, being recognized as a Great Place to Work in 2021, Fast Company’s Best Workplace for Innovators in 2020, and Forbes JUST companies in 2020, among others.